IL147095A0 - Retro-inverso peptides derived from leukemia inhibitory factor - Google Patents

Retro-inverso peptides derived from leukemia inhibitory factor

Info

Publication number
IL147095A0
IL147095A0 IL14709500A IL14709500A IL147095A0 IL 147095 A0 IL147095 A0 IL 147095A0 IL 14709500 A IL14709500 A IL 14709500A IL 14709500 A IL14709500 A IL 14709500A IL 147095 A0 IL147095 A0 IL 147095A0
Authority
IL
Israel
Prior art keywords
retro
peptides derived
inhibitory factor
leukemia inhibitory
inverso peptides
Prior art date
Application number
IL14709500A
Other languages
English (en)
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of IL147095A0 publication Critical patent/IL147095A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL14709500A 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor IL147095A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13968599P 1999-06-16 1999-06-16
PCT/US2000/016760 WO2000077029A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor

Publications (1)

Publication Number Publication Date
IL147095A0 true IL147095A0 (en) 2002-08-14

Family

ID=22487838

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14709500A IL147095A0 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor
IL147095A IL147095A (en) 1999-06-16 2001-12-13 Retro-inverso peptides derived from leukemia inhibitory factor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147095A IL147095A (en) 1999-06-16 2001-12-13 Retro-inverso peptides derived from leukemia inhibitory factor

Country Status (6)

Country Link
EP (1) EP1183266A4 (enExample)
JP (2) JP2003502341A (enExample)
AU (1) AU5622700A (enExample)
CA (1) CA2376474A1 (enExample)
IL (2) IL147095A0 (enExample)
WO (1) WO2000077029A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
EP1267911A4 (en) * 2000-03-03 2004-04-21 Amrad Corp Ltd TREATMENT METHOD
AU3713201A (en) * 2000-03-03 2001-09-12 Inst Medical W & E Hall A method of treatment
CA2645245A1 (en) * 2006-03-31 2007-10-11 Queen's University At Kingston Compositions and methods for treating atherosclerosis
KR20180029201A (ko) 2015-05-18 2018-03-20 티씨알2 테라퓨틱스 인크. 융합 단백질을 이용하는 tcr 리프로그래밍을 위한 조성물 및 방법
JP7291396B2 (ja) 2016-11-22 2023-06-15 ティーシーアール２ セラピューティクス インク． 融合タンパク質を用いたｔｃｒの再プログラミングのための組成物及び方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843892A (en) * 1989-12-18 1998-12-01 California Institute Of Technology Stimulation of nerve growth and/or vitality
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
EP0979238A4 (en) * 1997-03-05 2000-08-23 Univ California METHOD FOR HEALING NEUROPATHIC PAIN
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Also Published As

Publication number Publication date
IL147095A (en) 2010-12-30
AU5622700A (en) 2001-01-02
JP2003502341A (ja) 2003-01-21
CA2376474A1 (en) 2000-12-21
EP1183266A4 (en) 2002-10-23
WO2000077029A1 (en) 2000-12-21
EP1183266A1 (en) 2002-03-06
JP2011144184A (ja) 2011-07-28

Similar Documents

Publication Publication Date Title
GB0128994D0 (en) Peptides
GB9929464D0 (en) Complementary peptide ligande generated from the human genome
EP1534308A4 (en) PEPTIDES WITH INHIBITORY ACTION OF GROWTH
GB0100196D0 (en) Peptides
IL147095A (en) Retro-inverso peptides derived from leukemia inhibitory factor
GB9825854D0 (en) Peptide
EP1185558A4 (en) PEPTIDES WITH PREPTID FUNCTIONALITY
GB9904695D0 (en) Peptide
AU2973100A (en) Novel agouti and agouti-related peptide analogs
EP1147130A4 (en) ALPHA-conotoxin PEPTIDE
GB9812675D0 (en) Peptides
IL147093A0 (en) Retro-inverso peptides derived from interleukin-3
HK1042713A (en) Retro-inverso peptides derived from leukemia inhibitory factor
IL147094A0 (en) Retro-inverso peptides derived from interleukin-6
GB0120713D0 (en) Peptides
HK1042712A (en) Retro-inverso peptides derived from interleukin-6
GB9807890D0 (en) Peptides
HK1042711A (en) Retro-inverso peptides derived from interleukin-3
IL143950A0 (en) Polypeptides derived from jnk3
IL149355A0 (en) Polypeptide corporation
GB9907911D0 (en) Peptides
GB9918597D0 (en) Novel peptides
GB9918594D0 (en) Novel peptides
GB9918604D0 (en) Novel peptides
GB9918606D0 (en) Novel peptides